Stem Cell Extraction System

[INQ. NO. 2602E05] Miracell Co., Ltd. is a stem cell company specializing in stem cell-based regenerative medicine, accumulating unparalleled technological prowess.
Miracell’s proprietary stem cell extraction system, Smart M-Cell, and its dedicated kit are medical devices approved by Korea’s Ministry of Food and Drug Safety as stem cell products. Having received FDA registration and CE certification, the system meets global regulatory standards and is characterized by their ability to extract high-quality multi-cells with maximized stem cell viability.
Smart M-Cell is a system that automatically extracts and concentrates stem cells from blood or bone marrow, achieving cell viability rates of up to 99%. It can simultaneously extract more than five key regenerative cell types, including stem cells, growth factors, white blood cells, and SDF-1α, making it ideal for customized regenerative medicine treatments tailored to specific treatment goals.
Currently, Smart M-Cell is used in over 600 hospitals and clinics in Korea and in over 40 countries worldwide.

Miracell’s technological prowess and reliability have been recognized through global deployments spanning Europe, the Middle East, Asia, and the Americas.
Smart M-Cell’s applications are expanding beyond knee joint treatment to include brain function enhancement, skin improvement, and cosmetic and plastic surgery procedures. Considering the importance of stem cell extraction systems, a key component in regenerative medicine, Smart M-Cell is considered a foundational technology that enhances treatment consistency and efficiency.
Miracell is also introducing the ‘Chroma M-Cell,’ a next-generation solution designed to maximize the effectiveness of stem cell treatment. Chroma M-Cell is the world’s first ringer bag-covered device that utilizes photobiomodulation technology to enhance cell vitality during stem cell ringer injection.
The device’s core function is to enhance cellular physiological activity and stabilize cell instability when exposed to the external environment by irradiating it with light of a specific wavelength. Four wavelengths — red, blue, yellow, and green — can be selected based on the treatment objective, enabling the product’s applications to be further expanded into diverse fields such as regenerative medicine, skin regeneration, and immune enhancement. Chroma M-cell, used in conjunction with Smart M-cell, is positioned as a complementary solution that elevates the effectiveness of stem cell treatment.
Miracell is actively targeting Russia, South America, China, and Japan as key target markets and is actively pursuing the global regenerative medicine market. The company is pursuing global standardization of Smart M-cell, focusing on countries where demand for stem cell treatment is rapidly growing due to aging populations and the rise of chronic diseases.

China and Russia, in particular, are considered markets with a high level of acceptance of alternative treatments, while South America is seen as a market with growing demand for combined aesthetic and regenerative medicine treatments. Japan, with its strong institutional support for regenerative medicine, is expected to have a high potential for early market penetration.
Miracell plans to actively promote Korea’s stem cell extraction technology, focusing on Smart M-Cell and Chroma M-cell, at major global exhibitions such as IMCAS (Paris), Dubai Stem Cell Congress, AAOS 2026, Dubai Derma 2026, INTERCHARM Moscow, and MEDICA (Düsseldorf). Through this, the company’s strategy is to verify its technological prowess, safety, and scalability on the international stage and further strengthen its position as a global platform company in the field of regenerative medicine.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods